Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Lamictal TM, Haloperidol Decanoate in Schizophrenia (CMCOBaku)

This study has been terminated.
(All of the mentioned aim and objectives were achieved before the February 2007)
Sponsor:
Information provided by:
Central Mental Clinic for Outpatients of Baku City
ClinicalTrials.gov Identifier:
NCT00947375
First received: July 20, 2009
Last updated: July 27, 2009
Last verified: July 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2007
  Primary Completion Date: January 2006 (Final data collection date for primary outcome measure)